Federal Council approves Swissmedic's strategic goals for 2023–2026

16 dicembre 2022 – At its meeting held on 9 December 2022, the Federal Council approved the strategic goals of the Swiss Agency for Therapeutic Products (Swissmedic) for 2023–2026: Efficient, independent therapeutic products oversight, expansion of national and international cooperation, and trustworthy communication with the public remain focal points. Greater emphasis will be placed on support for innovation and advancing digitalisation in the new strategy period.

For more information, see here.